rapidly progressive glomerulonephritis
ORPHA: 2805691 Treatment Available
Overview
human disease
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| rituximab Orphan Cold Chain | IV infusion 10mg/mL (100mg/10mL, 500mg/50mL vials) | FDA Approved | 11 | 14d |
Classification & Codes
Orphanet Code
ORPHA:280569rapidly progressive glomerulonephritis
| Orphanet | ORPHA:280569 |
| Treatments | 1 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO